WHAT THE HUMAN DATA SAY
Evidence before enthusiasm.
Prescription products clearly lower high triglycerides, while cardiovascular outcome results differ by population, dose and formulation. General low-dose supplementation has not produced uniform outcome benefits.
This grade reflects clinically meaningful human evidence for the use described here. It is not a score for popularity, mechanism, animal lifespan results or the number of products already being sold.
HOW IT FITS
A practical role—without pretending it is universal.
Prioritize fatty fish when appropriate. If supplementing, verify the actual EPA+DHA amount, oxidation control and contaminant testing rather than buying by total fish-oil weight.
TRACK WHAT MATTERS
Know whether it is creating value.
Dietary fish intake
Triglycerides or clinician-selected markers
Bruising, bleeding and medication context
SAFETY & BOUNDARIES
What should make you pause.
- Anticoagulants, bleeding disorders and atrial-fibrillation risk deserve review.
- Avoid oxidized or poorly documented oils.
BOOK CONNECTIONS
Where this idea enters the longevity conversation.
Book inclusion explains why the idea is culturally important; the evidence grade above determines how strongly The Modern Bio treats the claim.